http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006115137-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 |
| filingDate | 2006-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2006115137-A1 |
| titleOfInvention | 2-Aminobenzimidazole derivatives and their pharmaceutical use |
| abstract | The present invention provides 2-aminobenzimidazole derivatives useful for diseases caused by abnormal plasma uric acid levels. That is, a 2-aminobenzimidazole derivative represented by the following formula (I) [wherein R 1 is a halogen atom or the like, m is 0 to 2, n is 1 to 2, R 2 is OH or the like, R 3 and R 4 is H or OH, ring Q is a heterocyclic or bicyclic hydrocarbon group, R 5 and R 6 are cyano groups, -AH, -A-D-E-G groups, etc. {A is a single bond, O, S , NR 8 or the like; D is optionally substituted alkylene group, alkenylene group or the like; E is a single bond, O, S, NR 9 ( R 8, R 9 is H or an optionally substituted alkyl group), optionally substituted (hetero) cycloalkylene group , (Hetero) arylene group, etc .; G represents H, substituted alkyl group, alkenyl group, etc.}, R 7 represents H, halogen atom, replaceable (hetero) aryl group, etc.}. Or a prodrug thereof or a pharmacologically acceptable salt thereof, or a pharmaceutical composition containing the same as an active ingredient. [Chemical 1] |
| priorityDate | 2005-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 270.